Sanner

Executive Summary

Sanner Group is a German-based global leader in medical device development and pharmaceutical/nutraceutical packaging solutions. Founded in 2021, the company specializes in moisture protection and drug delivery systems, offering full-service CDMO capabilities from design and engineering to commercial manufacturing. Its core expertise lies in injection molding and desiccant integration, ensuring product stability and reliability. With a focus on serving the pharmaceutical, nutraceutical, and medical device industries, Sanner provides critical packaging solutions that maintain product integrity during storage and transport, as well as advanced drug delivery devices that improve patient outcomes. The company's integrated approach positions it as a valuable partner for both established pharmaceutical companies and emerging biotech firms seeking to bring new therapies to market efficiently. Sanner's market position is strengthened by its deep technical expertise and quality-focused manufacturing, which are essential in the highly regulated pharmaceutical packaging and medical device sectors. The growing demand for advanced drug delivery systems, particularly for biologics and self-administration devices, presents significant growth opportunities. Additionally, increasing emphasis on product protection and shelf-life extension in nutraceuticals supports demand for Sanner's moisture-proof packaging. As the company continues to expand its CDMO services and potentially enter new geographic markets, it is well-positioned to capture a larger share of the pharmaceutical packaging and medical device outsourcing market. However, as a private company with limited public information, its growth trajectory will depend on securing new contracts and maintaining regulatory compliance.

Upcoming Catalysts (preview)

• Q3 2026Announcement of Major CDMO Contract with Top-20 Pharma Company60% success
• Q4 2026Regulatory Approval (FDA/EMA) for a Novel Drug Delivery Device65% success
• Q2 2027Expansion of Manufacturing Capacity in Germany or Abroad55% success